PearlMatrixTM Peptide Enhanced Bone Graft
Cerapedics, Inc. · Decision date Sep 16, 2026
What did the FDA decide?
Cerapedics, Inc. holds PMA P240001 for a synthetic peptide bone void filler (product code NOX, orthopedic). Supplement S003, a 30-Day Notice categorized as a process change involving a manufacturer, sterilizer, packager, or supplier, was filed to cover changes in P-15 manufacturing at Bachem Americas. The stated purpose is "equipment technological advancements and to improve process efficiency," alongside a series of minor or administrative specification changes. Because the record identifies this as a supplement to P240001, it is a modification notice tied to the existing approval, not an original PMA and not a new approval of the whole device system.
The supplied statement is broad. It does not name specific equipment, quantify the efficiency change, list which specifications moved, or report data on product performance. The reported purpose describes the manufacturer's rationale; it is not independent evidence of safety or clinical effectiveness, and no clinical use or new indication can be drawn from it.
FDA approval order statement
changes to the P-15 manufacturing occurring at Bachem Americas due to equipment technological advancements and to improve process efficiency , as well as a series of minor/administrative specifications changes
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Orthopedic
- Decision date
- Sep 16, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P240001/S003
- Regulatory pathway
- PMA supplement
- Applicant
- Cerapedics, Inc.
- Product code
- NOX
- Decision code
- OK30
- Decision date
- Sep 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Filler, bone void, synthetic peptide.
- Applicant
- Cerapedics, Inc.
- Product code
- NOX
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P240001. Subsequent supplements may change the device or its indications.
FDA decision timeline
P240001 · Original PMA
PearlMatrix Bone Graft
P240001/S003 received
Application receipt date recorded by FDA.
P240001/S003 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P240001. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P240001
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
PearlMatrix Bone GraftP240001 | Cerapedics, Inc. | PMA approval | Jun 18, 2025 | FDA |
Explore the linked device profile
Other records with product code NOX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
i-F ACTOR Peptide Enhanced Graft SubstituteP140019/S014 | Cerapedics, LLC | PMA supplement | Sep 16, 2026 | FDA |
| Cerapedics, LLC | PMA approval | Nov 3, 2015 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cerapedics, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 11025 Dover St., Suite 1600, Westminster, CO, 80021
Sources and methodology
- Original FDA record: P240001/S003
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
